Vancomycin (IV) manufacturers & suppliers

Vancomycin (Iv)

Form: Intravenous (IV) Injection

Strength: Lyophilized vials: 500 mg, 750 mg, 1 g; Premixed IV bags: 500 mg/100 mL, 1 g/200 mL

Reference Brands: Vancocin(US);

Category: Critical Care

Vancomycin IV is a glycopeptide antibiotic widely used in hospitals to treat severe Gram-positive infections, including MRSA, sepsis, endocarditis, and bone infections. It is available as a lyophilized powder (500 mg, 750 mg, 1 g) or in ready-to-infuse bags (500 mg/100 mL, 1 g/200 mL). In the US, Vancocin and generic Vancomycin are supplied by ANI, Pfizer, Fresenius, and Mylan. In the EU, Sandoz, Accord, and Hikma lead distribution. Vancomycin is essential in critical care and infectious disease treatment. Pharma B2B platforms streamline Vancomycin bulk procurement for hospitals, clinics, and government tenders worldwide.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Glucagon

Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

View Details
Insulin (Iv)

Strength: 100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View Details
Flumazenil

Strength: 0.1 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) injection

Reference Brands: Romazicon®(US), Anexate®(EU)

View Details
Naloxone

Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View Details

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.